Related Experiment Video

Updated: Mar 25, 2026

Detecting Protein Subcellular Localization by Green Fluorescence Protein Tagging and 4',6-Diamidino-2-phenylindole Staining in Caenorhabditis elegans
09:36

Detecting Protein Subcellular Localization by Green Fluorescence Protein Tagging and 4',6-Diamidino-2-phenylindole Staining in Caenorhabditis elegans

Published on: July 30, 2018

10.2K

The Emerging Function and Mechanism of ceRNAs in Cancer

Yunfei Wang1, Jiakai Hou1, Dandan He1

  • 1Department of Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.

Trends in Genetics : TIG
|February 29, 2016
PubMed

Insights

Competing endogenous RNAs (ceRNAs) are key post-transcriptional regulators influencing gene expression. These RNA molecules play significant roles in cancer development by affecting tumorigenic and tumor-suppressive genes.

Area of Science:

  • Molecular Biology
  • Genetics
  • Oncology

Background:

  • Complex diseases like cancer involve altered gene expression.
  • Competing endogenous RNAs (ceRNAs) are emerging post-transcriptional regulators.
  • ceRNAs function via a microRNA (miRNA)-mediated mechanism.

Purpose of the Study:

  • To investigate the role of ceRNAs in cancer pathogenesis.
  • To understand how ceRNAs alter gene expression in tumors.
  • To explore ceRNAs as potential therapeutic targets in cancer.

Main Methods:

  • Analysis of gene expression data in solid tumors and hematopoietic malignancies.
  • Investigating miRNA-mediated regulatory networks.
  • Characterizing the function and mechanism of specific ceRNAs.

Main Results:

  • ceRNAs significantly impact cancer development.
  • ceRNAs modulate the expression of key cancer-related genes.
  • Evidence suggests ceRNAs are involved in both tumorigenic and tumor-suppressive pathways.

Conclusions:

  • ceRNAs are crucial regulators in cancer pathogenesis.
  • Understanding ceRNAs advances fundamental knowledge of RNA-mediated disease.
  • ceRNAs offer potential for novel RNA-based cancer therapies.

More Related Videos

Identification of EGFR and RAS Inhibitors using Caenorhabditis elegans08:12

Identification of EGFR and RAS Inhibitors using Caenorhabditis elegans

Published on: October 5, 2020

3.4K
Sequencing Small Non-coding RNA from Formalin-fixed Tissues and Serum-derived Exosomes from Castration-resistant Prostate Cancer Patients12:13

Sequencing Small Non-coding RNA from Formalin-fixed Tissues and Serum-derived Exosomes from Castration-resistant Prostate Cancer Patients

Published on: November 19, 2019

7.3K

Related Concept Videos

Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
7.3K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

4.2K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
8.4K
The Nucleolus02:55

The Nucleolus

The nucleolus is the most prominent substructure of the nucleus. When it was first discovered, it was considered to be an isolated organelle that forms fibrils and granules. In 1931, the relationship between the nucleolus and chromosomes was first described by Heitz. He observed that the appearance and size of nucleolus varies depending on the stage of the cell cycle. He also noticed constricted regions on different chromosomes clustered together at definite cell cycle stages. These regions,...
10.7K
Cadherins in Tissue Organization01:19

Cadherins in Tissue Organization

The cadherins are a superfamily of cell adhesion molecules comprising over 180 variants, with specific tissues expressing a particular combination of cadherin types. Cadherins generally exhibit homophilic binding; i.e., cadherins on one cell bind to cadherins of the same or closely related type on another cell. Thus, cells of the same type have a specific affinity to bind to each other and sort themselves into clusters to form tissues.
Cell Sorting During Development
Cell sorting plays an...
4.5K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
6.2K